ADCs for HER2-Expressing Breast Cancer Market in China 2021
- Ulat sa Market
- ID: HL10091C
- Oras ng Paghahatid: 1 Araw ng Negosyo
- Tag: ADCs for HER2-Expressing Breast Cancer
Paglalarawan
The ADCs for HER2-expressing breast cancer market in China in terms of revenue is set to grow by US$ 373 milyon sa panahon ng 2021-2027, lumalaki sa isang compound taunang rate ng paglago (CAGR) ng mga 96.8% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix.
Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2017-2020 at forecast na 2027 covering key market aspects like sales value for ADCs for HER2-expressing breast cancer. The China ADCs for HER2-expressing breast cancer market is segmented on the basis of region. By region, it is categorized into Central South China, East China, North China, Northeast China, Northwest China, and Southwest China.
The report has profiled some of the key players of the market such as Daiichi Sankyo Company Limited, Roche Holding AG, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd..
Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the ADCs for HER2-expressing breast cancer market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.
Saklaw ng Ulat
Rehiyon: Central South China, East China, North China, Northeast China, Northwest China, and Southwest China
Mga Taon na Itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2017 sa 2027
Mga Pangunahing Benepisyo para sa mga Stakeholder
Get a comprehensive picture of the China ADCs for HER2-expressing breast cancer market
Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan
Understand what the future of the ADCs for HER2-expressing breast cancer market in China looks like
Kilalanin ang mapagkumpitensya na landscape at window ng pagkakataon
Talaan ng mga Nilalaman
1. Kahulugan ng Market
2. Metodolohiya ng Pananaliksik
3. Market Data & Outlook
3.1 Halaga ng Market
3.2 Pagtataya ng Halaga sa Market
4. ADCs for HER2-Expressing Breast Cancer Market by Region
4.1 Central South China
4.2 East China
4.3 North China
4.4 Northeast China
4.5 Northwest China
4.6 Southwest China
5. Mga Profile ng Kumpanya
5.1 Daiichi Sankyo Company Limited
5.2 Roche Holding AG
5.3 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
6. Apendiks
6.1 Tungkol sa StrategyHelix
6.2 Pagtanggi
USD 450